For example, monoclonal antibodies or small molecule tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF) or its receptors 14 have showed high therapeutic efficiency in treatment of cancer. This evidence concerns the gene VEGFA and cancer.